Chun-Su Yuan to Quaternary Ammonium Compounds
This is a "connection" page, showing publications Chun-Su Yuan has written about Quaternary Ammonium Compounds.
Connection Strength
1.229
-
Pharmacologic treatment of opioid-induced constipation. Expert Opin Investig Drugs. 2013 Oct; 22(10):1225-7.
Score: 0.115
-
Methylnaltrexone potentiates body weight and fat reduction with leptin. J Opioid Manag. 2009 Nov-Dec; 5(6):373-8.
Score: 0.089
-
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells. Anticancer Res. 2009 Aug; 29(8):2927-32.
Score: 0.088
-
Methylnaltrexone reduced body weight gain in ob/ob mice. J Opioid Manag. 2009 Jul-Aug; 5(4):213-8.
Score: 0.087
-
Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Ann Pharmacother. 2007 Jun; 41(6):984-93.
Score: 0.075
-
Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects. Expert Opin Investig Drugs. 2006 May; 15(5):541-52.
Score: 0.070
-
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol. 2005 May; 45(5):538-46.
Score: 0.065
-
Methylnaltrexone prevents morphine-induced kaolin intake in the rat. Life Sci. 2004 Apr 16; 74(22):2685-91.
Score: 0.061
-
Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects. J Support Oncol. 2004 Mar-Apr; 2(2):111-7; discussion 119-22.
Score: 0.060
-
Determination of methylnaltrexone in clinical samples by solid-phase extraction and high-performance liquid chromatography for a pharmacokinetics study. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 25; 780(2):251-9.
Score: 0.055
-
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. J Pharmacol Exp Ther. 2002 Jan; 300(1):118-23.
Score: 0.052
-
Antagonism of gastrointestinal opioid effects. Reg Anesth Pain Med. 2000 Nov-Dec; 25(6):639-42.
Score: 0.048
-
Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 2000 Apr; 67(4):398-404.
Score: 0.046
-
Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA. 2000 Jan 19; 283(3):367-72.
Score: 0.045
-
Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain. 1999 Dec; 83(3):631-635.
Score: 0.045
-
Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses. Neuropharmacology. 1999 Mar; 38(3):425-32.
Score: 0.043
-
Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine. Drug Alcohol Depend. 1998 Oct 01; 52(2):161-5.
Score: 0.041
-
The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 1997 Apr; 61(4):467-75.
Score: 0.037
-
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther. 1996 Apr; 59(4):469-75.
Score: 0.035
-
Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine. Eur J Pharmacol. 1995 Mar 24; 276(1-2):107-11.
Score: 0.032
-
Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone. Anesth Analg. 2008 Dec; 107(6):1965-7.
Score: 0.021
-
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine. Cancer Chemother Pharmacol. 1998; 42(4):287-91.
Score: 0.010
-
Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study. J Clin Pharmacol. 1997 Jan; 37(1):25-30.
Score: 0.009